- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Prostatic Adenocarcinoma in South Africa
Total 1628 results
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
DendreonTerminatedCastration-Resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States, China, Hungary, Taiwan, Belgium, Germany, Spain, Italy, Czechia, France, Japan, Switzerland, Australia, Israel, Korea, Republic of, Canada, Russian Federation, Slovakia, United Kingdom, Turkey, Sweden, Greece, Finland, ... and more
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Watson PharmaceuticalsCompletedProstate CancerUnited States
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Bavarian NordicNational Cancer Institute (NCI); Therion Biologics CorporationCompletedProstate CancerUnited States
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
Debiopharm International SARecruitingProstate CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Exosome Diagnostics, Inc.Completed
-
Incyte CorporationTerminatedProstate CancerUnited States
-
Janssen Scientific Affairs, LLCCompletedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC; University of StellenboschWithdrawnHIV Infection | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | FIGO Stage IIB Cervix Carcinoma | FIGO Stage III Cervix Carcinoma | FIGO Stage IVA Cervix CarcinomaSouth Africa, Zimbabwe
-
Clarity Pharmaceuticals LtdRecruitingProstatic Neoplasms | Prostate CancerUnited States
-
Clarity Pharmaceuticals LtdCompletedBiochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingAdvanced/Metastatic Gastroesophageal AdenocarcinomaChina, Japan, Poland, Hong Kong, Korea, Republic of, Canada, United States, Argentina, Australia, Belgium, Chile, Colombia, Costa Rica, France, Germany, Guatemala, Ireland, Israel, Italy, Russian Federation, Spain, Taiwan, Turkey, United...
-
Boston Scientific CorporationAugmenix, Inc.Completed
-
British Columbia Cancer AgencyThe Alfred; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Cancer... and other collaboratorsRecruitingMetastatic TumorsCanada, Australia, United Kingdom, Ireland
-
Nymox CorporationCompletedProstate CancerUnited States
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Czech Republic, Hungary, Romania, Canada
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Genentech, Inc.Chugai Pharmaceutical Co.RecruitingGastric Cancer | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaKorea, Republic of, Spain, Japan, New Zealand, Australia, United States, Italy, Brazil
-
NewLink Genetics CorporationCompletedMetastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; North Central Cancer...CompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteBayer; Decipher BiosciencesRecruiting
-
Ferring PharmaceuticalsMemorial Sloan Kettering Cancer Center; Duke Clinical Research InstituteTerminatedProstate CancerUnited States, France, Canada, Czechia, Finland, Germany, Greece, Poland, Russian Federation, Slovakia, South Africa, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | PSA Level Five to Ten | PSA Level Less Than Five | PSA Level Ten to FiftyUnited States
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
GP-PharmCompletedProstate CancerUnited States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
-
AbbottCompletedProstate CancerUnited States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaboratorsCompletedProstate CancerUnited States, Australia, Peru, Puerto Rico
-
Gilead SciencesWithdrawnPancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast CancerSpain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama